Answer:
Research for species is done by microscopic view. The micro organism like fungi and bacteria are difficult to be observed by naked eye.
Explanation:
The research process includes the detailed view of the properties of micro organism. Their way of living separates them from each other. Parasites used to live in the body of their victim. 
 
        
             
        
        
        
Answer:
Metoclopramide is a drug widely used for its antiemetic effect (that is, used for the symptomatic treatment of nausea and vomiting). Its adverse reactions are varied, affecting even the central nervous system, causing extrapyramidal syndromes.
Explanation:
Due to the antidopaminergic action of metoclopramide. Signs and symptoms can range from spasms of the muscles of the face, neck or tongue, motor agitation and tremor, acatisia (feeling restless and in need of constant movement) and acute dystonic reactions. Extrapyramidal syndrome is transient and disappears after eliminating or decreasing the dose of metoclopramide.
Metoclopramide is a drug that can be administered intravenously. Its administration can be in bolus or by a continuous infusion. Is there any method of choice to prevent or reduce the occurrence of pyramidal syndromes?
A recent systematic review concluded that, compared with bolus administration, continuous intravenous infusion of metoclopramide reduced the occurrence of extrapyramidal side effects.
With this gesture we can perform quality care and try to avoid side effects to our patients.
 
        
             
        
        
        
Honestly it would be the Exosphere<span> but since that's not one of the choices it would be the Thermosphere. </span>
        
                    
             
        
        
        
I believe the answer is B. <span>The antibodies on B cells bind to the antigens on the pathogen's surface.
</span>
        
                    
             
        
        
        
Answer:
The correct answer is A the compound is a competitive inhibitor
Explanation:
Competitive inhibitor competes with the substrate to bind to the active site of the target enzyme and after binding to the active site the inhibitor slow down or stop the reaction catalyzed by that enzyme.
           Competitive inhibitor basically effects the Km value of the enzyme thus decreasing the activity of the later.
            Increasing the substrate concentration displace the inhibitor from the enzyme"s active site thus reducing the inhibitory effects of the later thus increasing the activity of the enzyme.